Medical net on July 21, the general administration of the general administration of Chinese medicine, and released a batch!
On July 20, the state administration of food and drug administration issued a notice that 26 batches of Chinese herbal medicines were disqualified.
▍ 20 drug firms are investigation, involved drug recall
Announcement: labeled sichuan koren natural pharmaceutical co., LTD., qiqihaer city in heilongjiang province, Chinese medicine yinpian processing factory, the crane, a Chinese medicine yinpian of Harbin pharmaceutical group co., LTD., Beijing tongrentang (bozhou) yinpian co., LTD., 20 companies such as production of 26 unqualified batch alum. The unqualified project is ammonium salt.
The relevant food and drug administration has taken control measures such as seizure and seizure, and ordered enterprises to suspend sales, recall products and rectify them.
Administration requirements for production and sales of unqualified drugs illegal behavior to carry on the investigation of public three months for production and sales of unqualified drugs processing result of relevant enterprises or units, and timely report the relevant situations.
▍ medicine is bad, medicine will be good?
Administration for Chinese medicine yinpian checking aggressively this year, accordingly, will release a lot about Chinese medicine yinpian unqualified notice, in the slash market at the same time, also caused some discussion about this topic.
For example, some readers said, "there are many problems in the Chinese herbal medicine market, so I would like to know that the traditional Chinese medicine preparation can be qualified.
This is a question that needs to be interpreted by professionals in the pharmaceutical industry, but it may also be the purpose of the regulator's regulatory efforts. However, while increasing the intensity of the supervision, Chinese medicine is also thought to have ushered in the "golden development period".
▍ intensify supervision, yinpian usher in a golden development
"The market is becoming more and more regulated as the country increases its inspection efforts. However, the supply of quality products is relatively small and the price will be relatively high." One industry source said high quality prices would be a big trend. In addition, the policy dividend will promote the development of traditional Chinese medicine.
Released in May 2015, the state council general office on the city public hospital comprehensive reform pilot guidance ", pilot cities all public hospitals to promote medical apart, actively explore a variety of effective ways to reform to medicine medical mechanism, cancel the drug addition (except traditional Chinese medicine yinpian), the 2017 pilot cities to public hospital medicine proportion (excluding Chinese medicine yinpian) overall to around 30%.
The state regulation has been continuously tightened, and Chinese medicines have been listed in the black list. However, it is also noted that the improvement of quality of traditional Chinese medicine in the stimulus of policy dividend can make its development better.
Attached: 26 batches of unqualified Chinese medicine
|
